Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model

Annals of Nutrition and Metabolism

Volumn 56, Issue 3, 2010, Pages 198-206

  Zago, V ^a   Lucero, D ^a   MacRi, E V ^b   Cacciagiu L ^a   Gamba, C A ^b   Miksztowicz, V ^a   Berg, G ^a   Wikinski, R ^a   Friedman, S ^b   Schreier, L ^a  

^a University of Buenos Aires   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Fatty liver; Insulin resistance; Sucrose rich diet; Very low density lipoprotein composition; Very low density lipoprotein secretion

Indexed keywords

DRINKING WATER; SUCROSE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL OBESITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BODY FAT; CALORIC INTAKE; CONTROLLED STUDY; DIETARY INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; FATTY LIVER; INSULIN RESISTANCE; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SECRETION; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUGAR INTAKE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL, HDL; ENERGY INTAKE; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; INSULIN RESISTANCE; LIPID METABOLISM; LIPID PEROXIDATION; LIPOPROTEINS, VLDL; LIVER; MALE; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES;

RATTUS;

EID: 77951478559     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000276596     Document Type: Article

References (37)

1. Adams LA, Angulo P, Lindor KD: Nonalcoholic fatty liver disease. CMAJ 2005; 172: 899-905. (Pubitemid 40543601)
2. Avramoglu RK, Qiu W, Adeli K: Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion. Front Biosci 2003; 8:d464-d476. (Pubitemid 38943204)
3. Lewis GF, Carpentier A, Adeli K, Giacca A: Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002; 23: 201-229. (Pubitemid 34299024)
4. Gaemers IC, Groen AK: New insights in the pathogenesis of non-alcoholic fatty liver disease. Curr Opin Lipidol 2006; 17: 268-273. (Pubitemid 43786060)
5. Tomkin GH, Owens D: Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis. Diabetes Metab Res Rev 2001; 17: 27-43. (Pubitemid 32203869)
6. Krauss RM: Atherogenicity of triglyceriderich lipoproteins. Am J Cardiol 1998; 81: 13B- 17B.
7. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Hakkinen A, Olofsson SO, Yki- Jarvinen H, Boren J: Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 2006; 49: 755-765. (Pubitemid 43357551)
8. Toledo FG, Sniderman AD, Kelley DE: Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes. Diabetes Care 2006; 29: 1845- 1850.
9. Gutman RA, Basilico MZ, Bernal CA, Chicco A, Lombardo YB: Long-term hypertriglyceridemia and glucose intolerance in rats fed chronically an isocaloric sucrose-rich diet. Metabolism 1987; 36: 1013-1020. (Pubitemid 18025027)
10. Fortino MA, Lombardo YB, Chicco A: The reduction of dietary sucrose improves dyslipidemia, adiposity, and insulin secretion in an insulin-resistant rat model. Nutrition 2007; 23: 489-497. (Pubitemid 46901013)
11. Ponzo O, Schreier L, Resnik R, Negri G, Scacchi P, Cresta MA, Wikinski R: Endogenous hypertriglyceridemia intensifies the course of cerulein-induced pancreatitis in rat: relation with changes in the VLDL composition. Ann Nutr Metab 2006; 50: 37-44. (Pubitemid 43097642)
12. Institute of Laboratory Animal Resources CoLS: National Research Council Guide for the Care and Use of Laboratory Animals, ed 7. Washington, National Academy Press, 1996, p 125.
13. Schumaker VN, Puppione DL: Sequential flotation ultracentrifugation. Methods Enzymol 1986; 128: 155-170.
14. Bartlett GR: Phosphorus assay in column chromatography. J Biol Chem 1959; 234: 466-468.
15. Valls C, Iannacconne R, Alba E, Murakami T, Hori M, Passariello R, Vilgrain V: Fat in the liver: diagnosis and characterization. Eur Radiol 2006; 16: 2292-2308. (Pubitemid 44349878)
16. Bernal CA, Basilico MZ, Gutman R, Lombardo YB: Secretion and removal rates of very low density lipoprotein triglycerides at the three metabolic periods of hypertriglyceridemia induced by sucrose rich diet. Nutr Rep Int 1989; 40: 71-83. (Pubitemid 19176036)
17. Otway S, Robinson DS: The effect of a nonionic detergent (Triton WR 1339) on the removal of triglyceride fatty acids from the blood of the rat. J Physiol 1967; 190: 309-319.
18. Wang CF, Hegsted DM: Normal blood volume, plasma volume and thiocyanate space in rats and their relation to body weight. Am J Physiol 1949; 156: 218-226.
19. Aguilera AA, Diaz GH, Barcelata ML, Guerrero OA, Ros RM: Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor- in rats with sucrose-induced metabolic syndrome. J Nutr Biochem 2004; 15: 350-357.
20. Lombardo YB, Drago S, Chicco A, Fainstein- Day P, Gutman R, Gagliardino JJ, Gomez Dumm CL: Long-term administration of a sucrose-rich diet to normal rats: relationship between metabolic and hormonal profiles and morphological changes in the endocrine pancreas. Metabolism 1996; 45: 1527-1532. (Pubitemid 26424582)
21. Ruzzin J, Lai YC, Jensen J: Consumption of carbohydrate solutions enhances energy intake without increased body weight and impaired insulin action in rat skeletal muscles. Diabetes Metab 2005; 31: 178-188. (Pubitemid 40577202)
22. Chalasani N, Deeg MA, Crabb DW: Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004; 99: 1497-1502. (Pubitemid 39193189)
23. Marchesini G, Marzocchi R, Agostini F, Bugianesi E: Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005; 16: 421-427. (Pubitemid 41017626)
24. Svegliati-Baroni G, Candelaresi C, Saccomanno S, Ferretti G, Bachetti T, Marzioni M, De Minicis S, Nobili L, Salzano R, Omenetti A, Pacetti D, Sigmund S, Benedetti A, Casini A: A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor- and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol 2006; 169: 846-860. (Pubitemid 44411952)
25. Pont F, Duvillard L, Florentin E, Gambert P, Vergès B: Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity. Arterioscler Thromb Vasc Biol 2002; 22: 1726-1732.
26. Olofsson SO, Boström P, Andersson L, Rutberg M, Perman J, Borén J: Lipid droplets as dynamic organelles connecting storage and efflux of lipids. Biochim Biophys Acta 2009; 1791: 448-458.
27. Wei E, Alam M, Sun F, Agellon LB, Vance DE, Lehner R: Apolipoprotein B and triacylglycerol secretion in human triacylglycerol hydrolase transgenic mice. J Lipid Res 2007; 48: 2597-2606. (Pubitemid 350272844)
28. Shelness GS, Sellers JA: Very-low-density lipoprotein assembly and secretion. Curr Opin Lipidol 2001; 12: 151-157.
29. de Grooth GJ, Klerkx AH, Stroes ES, Stalenhoef AF, Kastelein JJ, Kuivenhoven JA: A review of CETP and its relation to atherosclerosis. J Lipid Res 2004; 45: 1967-1974.
30. Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC: Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003; 285:E906-E916. (Pubitemid 37176440)
31. Lewis GF, Uffelman KD, Szeto LW, Steiner G: Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 1993; 42: 833-842. (Pubitemid 23151575)
32. Gianturco SH, Bradley WA: Lipoproteinmediated cellular mechanisms for atherogenesis in hypertriglyceridemia. Semin Thromb Hemost 1988; 14: 165-169.
33. Maggi FM, Raselli S, Grigore L, Redaelli L, Fantappie S, Catapano AL: Lipoprotein remnants and endothelial dysfunction in the postprandial phase. J Clin Endocrinol Metab 2004; 89: 2946-2950. (Pubitemid 38766390)
34. Norata GD, Grigore L, Raselli S, Redaelli L, Hamsten A, Maggi F, Eriksson P, Catapano AL: Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies. Atherosclerosis 2007; 193: 321-327. (Pubitemid 47064402)
35. Schreier L, Berg G, Zago V, Gonzalez AI, Wikinski R: Kinetics of in vitro lipolysis of human very low-density lipoprotein by lipoprotein lipase. Nutr Metab Cardiovasc Dis 2002; 12: 13-18. (Pubitemid 135712742)
36. Milosavljevic D, Kontush A, Griglio S, Le Naour G, Thillet J, Chapman MJ: VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass. Biochim Biophys Acta 2003; 1631: 51-60. (Pubitemid 36165103)
37. de Ferranti S, Mozaffarian D: The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008; 54: 945-955. (Pubitemid 351793400)